Evaluation of CSF biomarkers for axonal and neuronal degeneration, gliosis, and beta-amyloid metabolism in Alzheimer's disease.
Andreasen
N
N
Gottfries
J
J
Vanmechelen
E
E
Vanderstichele
H
H
Davidson
P
P
Blennow
K
K
Rosengren
L
L
Blennow
K
K
D000368:Aged; D015415:Biomarkers / Q000134:cerebrospinal fluid*; D005260:Female; D005911:Gliosis / Q000134:cerebrospinal fluid / Q000175:diagnosis*; D006801:Humans; D008297:Male; D009410:Nerve Degeneration / Q000134:cerebrospinal fluid / Q000175:diagnosis*; D009419:Nerve Tissue Proteins / Q000134:cerebrospinal fluid*; D011237:Predictive Value of Tests; D012183:Retrograde Degeneration / Q000134:cerebrospinal fluid / Q000175:diagnosis*
D015415:Biomarkers; D009419:Nerve Tissue Proteins